Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease

被引：24
作者：
Huff-Hardy, Kayci [1 ]
Bedair, Mai [2 ]
Vazquez, Rebecca [2 ]
Burstein, Ezra [1 ]
机构：
[1] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
[2] UT Southwestern Med Ctr, Dept Dermatol, Dallas, TX USA
来源：
INFLAMMATORY BOWEL DISEASES | 2017年 / 23卷 / 10期
关键词：
MAINTENANCE THERAPY; INDUCTION;
D O I：
10.1097/MIB.0000000000001232
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E49 / E49
页数：1
相关论文
共 50 条
  • [1] Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But Not Ustekinumab in Refractory Crohn's Disease
    Alric, Hadrien
    Amiot, Aurelien
    Kirchgesner, Julien
    Treton, Xavier
    Allez, Mathieu
    Bouhnik, Yoram
    Beaugerie, Laurent
    Carbonnel, Franck
    Meyer, Antoine
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (02) : 218 - 225
  • [2] Dual Biologic Therapy Induces Remission in Refractory Crohn's Disease With Vedolizumab and Ustekinumab
    Hassan, Syed Adeel
    Perry, Courtney
    Carey, Patrick
    Colohan, Durham
    Eltaher, Mohamed Gebril
    Dawoud, Nabila
    Elkammar, Mahmoud
    Rasheed, Waqas
    Mayne, Casie
    Stuffelbeam, Amy
    Flomenhoft, Deborah
    Barrett, Terrence A.
    CROHNS & COLITIS 360, 2025, 7 (01)
  • [3] The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab
    Kassouri, Liza
    Amiot, Aurelien
    Kirchgesner, Julien
    Treton, Xavier
    Allez, Mathieu
    Bouhnik, Yoram
    Beaugerie, Laurent
    Carbonnel, Franck
    Meyer, Antoine
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (10) : 1148 - 1155
  • [4] Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn?s disease
    Melotti, Laura
    Dussias, Nikolas Konstantine
    Salice, Marco
    Calabrese, Carlo
    Baldoni, Monia
    Scaioli, Eleonora
    Belluzzi, Andrea
    Mazzotta, Elena
    Gionchetti, Paolo
    Rizzello, Fernando
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (02) : 230 - 234
  • [5] Long-term Efficacy of Vedolizumab for Crohn's Disease
    Vermeire, Severine
    Loftus, Edward V., Jr.
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Sandborn, William J.
    Sands, Bruce E.
    Danese, Silvio
    D'Haens, Geert R.
    Kaser, Arthur
    Panaccione, Remo
    Rubin, David T.
    Shafran, Ira
    McAuliffe, Megan
    Kaviya, Arpeat
    Sankoh, Serap
    Mody, Reema
    Abhyankar, Brihad
    Smyth, Michael
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (04) : 412 - 424
  • [6] Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease
    Lee, Scott David
    Singla, Anand
    Harper, Jason
    Barahimi, Mitra
    Jacobs, Jeffrey
    Kamp, Kendra J.
    Clark-Snustad, Kindra Dawn
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (02) : 309 - 313
  • [7] Combination Therapy With Intensive Granulocyte and Monocyte Adsorptive Apheresis Plus Ustekinumab in Patients With Refractory Crohn's Disease
    Tanida, Satoshi
    Mizoshita, Tsutomu
    Ozeki, Keiji
    Katano, Takahito
    Tanaka, Mamoru
    Nishie, Hirotada
    Shimura, Takaya
    Okamoto, Yasuyuki
    Kubota, Eiji
    Kataoka, Hiromi
    Joh, Takashi
    THERAPEUTIC APHERESIS AND DIALYSIS, 2018, 22 (03) : 295 - 300
  • [8] Predictive factors of the clinical efficacy of ustekinumab in patients with refractory Crohn's disease: tertiary centers experience in Japan
    Esaki, Motohiro
    Ihara, Yutaro
    Tominaga, Naoyuki
    Takedomi, Hironobu
    Tsuruoka, Nanae
    Akutagawa, Takashi
    Yukimoto, Takahiro
    Kawasaki, Keisuke
    Umeno, Junji
    Torisu, Takehiro
    Sakata, Yasuhisa
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2023, 38 (01)
  • [9] The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor
    Alric, Hadrien
    Amiot, Aurelien
    Kirchgesner, Julien
    Treton, Xavier
    Allez, Mathieu
    Bouhnik, Yoram
    Beaugerie, Laurent
    Carbonnel, Franck
    Meyer, Antoine
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (10) : 948 - 957
  • [10] Patients with Refractory Crohn's Disease Successfully Treated with Ustekinumab
    Harris, Kimberly A.
    Horst, Sara
    Gadani, Akash
    Nohl, Anne
    Annis, Kim
    Duley, Caroline
    Beaulieu, Dawn
    Ghazi, Leyla
    Schwartz, David A.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (02) : 397 - 401
12345